Comparison of NIV-NAVA vs. N-CPAP After Extubation in Preterm Infants Study

NCT02590757 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2021-12-07

No results posted yet for this study

Summary

This study is a randomized controlled study to compare if a a non-invasive neurally adjusted ventilatory assist (NIV-NAVA) is better than nasal continuous positive airway pressure (N-CPAP) after extubation in infants' \< 30 weeks of gestation.

Conditions

  • Endotracheal Extubation
  • Infant, Premature

Interventions

DEVICE

NIV-NAVA

Non-invasive neurally adjusted ventilatory assist

DEVICE

N-CPAP

Nasal-continuous positive airway pressure

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Han-Suk Kim, MD, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Days
Max Age
6 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-10
Primary Completion
2020-11-13
Completion
2021-01-23

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02590757 on ClinicalTrials.gov